Clinical Trials in Salt Lake City

Showing 10161-10180 of 14,325 trials

Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis

NCT00556439

Giant cell arteritis (GCA) and Takayasu's arteritis (TAK) are diseases that cause swelling of the arteries in the head, neck, upper body, and arms. TAK specifically affects the aorta, the largest blood vessel in the body, and its branches. Therapies are available to improve the symptoms of GCA and TAK, but relapse often occurs, and better treatments are needed. Abatacept is a drug that interacts with certain cells in the body that are involved with GCA and TAK. This study will evaluate the effectiveness of abatacept in treating GCA and TAK and preventing disease relapse.

Takayasu's ArteritisGiant Cell Arteritis

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)97 participantsStarted Dec 2008

Los Angeles, California, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +7 more locations

COMPLETEDPhase 2< 1 mile

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

NCT01210222

This phase II trial studies the side effects and how well trebananib works in treating patients with persistent or recurrent endometrial cancer. Trebananib may stop the growth of endometrial cancer by blocking blood flow to the tumor.

Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+4 more

Gynecologic Oncology Group35 participantsStarted Jun 2011

Hartford, Connecticut, United States • New Britain, Connecticut, United States • Sarasota, Florida, United States +30 more locations

Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Find Trials by Condition in Salt Lake City

Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Extension Study of Gelesis100 on Body Weight

Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer

A Study Of PF-06664178 In Patients With Advanced Solid Tumors

Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias

A Study Evaluating MM-310 in Patients With Solid Tumors

Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis

Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies

Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis

Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome

Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis

Prevention of Obesity in Military Communities - Fit4Duty